Global Myopia
And Presbyopia Treatment Market, by Disease Type (Myopia and Presbyopia),
by Treatment Type (Prescription Lenses, Contact Lenses, Surgery, Medication,
and Others), and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa), is estimated to be valued at US$ 17.9 Billion in 2020
and is expected to exhibit a CAGR of 8.1% over the forecast period (2020-2027),
as highlighted in a new report published by Coherent Market Insights.
High incidence rate of myopia and
presbyopia is expected to drive the global myopia and presbyopia treatment
market growth in the near future, For instance, according to the World Health
Organization (WHO) estimation in 2015, the global prevalence of myopia and high
myopia were estimated to affect 27% (1,893 Billion) and 2.8% (170 Billion) of
the world population, respectively, in 2010. As per Brien Holden Vision
lnstitute projection, the global prevalence of myopia and high myopia is
estimated to be 33% and 4.0% in 2020 and in 2050, it is projected that myopia
and high myopia will affect 52% (4,949 Billion) and 10.0% (925 Billion) of world
population, respectively.
Browse 32 Market Data Tables and
28 Figures spread through 152 Pages and in-depth TOC on "Global Myopia And
Presbyopia Treatment Market, by Disease Type (Myopia and Presbyopia), by
Treatment Type (Prescription Lenses, Contact Lenses, Surgery, Medication, and
Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle
East, and Africa) - Global Forecast to 2027"
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/4206
Manufacturers and various eye
care institutes are engaged in the development of novel prescription lenses and
eyewear, which can be used in the treatment of various eyesight related
problems/conditions such as myopia and presbyopia. Thus, development of such
novel products having potential to gain the U.S. FDA approvals is a robust
opportunity for the market players to launch such products in the market. For
instance, in November 2019, CooperVision, a manufacturer of soft contact
lenses, received the U.S. FDA approval for its MiSight 1 day contact lens. The
lens is designed for the management of myopia (to slow the progression of
myopia). The company decided to launch the MiSight 1 day contact lens in the
U.S. in March 2020.
Moreover, in November 2015,
Bausch + Lomb Incorporated, a manufacturer and supplier of contact lenses,
launched Lomb ULTRA contact lenses, which are new multifocal lenses, for
presbyopia. The Bausch + Lomb ULTRA contact lenses is featured with
MoistureSeal technology, and contains polyvinylpyrrolidone (PVP) for enhanced
wettability, and have the highest Dk/t (163) and lowest modulus (70). Thus,
such increasing product development and launches are driving the market growth.
Global Myopia and Presbyopia
Treatment Market: Impact of COVID-19 Pandemic
The outbreak of the coronavirus
(COVID-19) have impacted the eyewear industry, as it is facing some potential
threats such as people with eye disorder such as myopia and presbyopia are not
ready to leave there house or visit the eye clinics to get a routine eye exam.
Also the patients are putting off medical their eye treatments unless it is
absolutely necessary. This has decline the demand for eye wear products.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/myopia-and-presbyopia-treatment-market-4206
Key takeaways of the Global
Myopia and Presbyopia Treatment Market:
The global myopia and presbyopia
treatment market is expected to exhibit a CAGR of 8.1% over the forecast period
(2020–2027), owing to increasing approvals of contact and prescription lenses.
For instance, in November 2019, Menicon Co., Ltd. received PMA approval from
the U.S. Food and Drug Administration for its Menicon Z Night (tisilfocon A)
Contact Lenses for Overnight Wear.
LASIK surgery is one of the most
prominent treatments for myopia and presbyopia. Thus, increasing number of
LASIK (laser-assisted in situ keratomileusis) surgeries is expected to
contribute to growth of the global myopia and presbyopia treatment market. For
instance, according to the report published by SeedScientific (data gathered
from multiple sources), in 2019, over 690,000 LASIK procedures were performed,
globally.
Major players operating in the
global myopia and presbyopia treatment market include ALCON Inc., Bausch Health
Companies Inc., EssilorLuxottica (Essilor Ltd.), Johnson & Johnson Vision,
NIDEK CO. LTD., Topcon Corporation, Zeimer Ophthalmic Systems AG, and ZEISS
International
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/4206
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment